Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts. more
Time Frame | AKYA | Sector | S&P500 |
---|---|---|---|
1-Week Return | 7.08% | -2.27% | -0.57% |
1-Month Return | -29.28% | -3.96% | 1.21% |
3-Month Return | -22.79% | -9.7% | 7.57% |
6-Month Return | 3.18% | -3.37% | 11.45% |
1-Year Return | -48.17% | 3.71% | 28.48% |
3-Year Return | -81.84% | 3.8% | 29.52% |
5-Year Return | -91.29% | 39.78% | 90.66% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 42.24M | 42.44M | 54.92M | 74.86M | 96.63M | [{"date":"2019-12-31","value":43.71,"profit":true},{"date":"2020-12-31","value":43.92,"profit":true},{"date":"2021-12-31","value":56.83,"profit":true},{"date":"2022-12-31","value":77.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 17.57M | 16.54M | 20.70M | 31.47M | 40.33M | [{"date":"2019-12-31","value":43.58,"profit":true},{"date":"2020-12-31","value":41,"profit":true},{"date":"2021-12-31","value":51.33,"profit":true},{"date":"2022-12-31","value":78.03,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 24.66M | 25.91M | 34.22M | 43.39M | 56.30M | [{"date":"2019-12-31","value":43.8,"profit":true},{"date":"2020-12-31","value":46.01,"profit":true},{"date":"2021-12-31","value":60.77,"profit":true},{"date":"2022-12-31","value":77.06,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 58.39% | 61.04% | 62.31% | 57.96% | 58.27% | [{"date":"2019-12-31","value":93.72,"profit":true},{"date":"2020-12-31","value":97.97,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":93.02,"profit":true},{"date":"2023-12-31","value":93.51,"profit":true}] |
Operating Expenses | 38.17M | 37.40M | 71.44M | 109.60M | 104.27M | [{"date":"2019-12-31","value":34.82,"profit":true},{"date":"2020-12-31","value":34.12,"profit":true},{"date":"2021-12-31","value":65.19,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":95.14,"profit":true}] |
Operating Income | (13.50M) | (11.49M) | (37.23M) | (66.21M) | (57.67M) | [{"date":"2019-12-31","value":-1350400000,"profit":false},{"date":"2020-12-31","value":-1149200000,"profit":false},{"date":"2021-12-31","value":-3722500000,"profit":false},{"date":"2022-12-31","value":-6620800000,"profit":false},{"date":"2023-12-31","value":-5766800000,"profit":false}] |
Total Non-Operating Income/Expense | (2.93M) | (7.38M) | (6.89M) | (8.19M) | (10.79M) | [{"date":"2019-12-31","value":-293400000,"profit":false},{"date":"2020-12-31","value":-737600000,"profit":false},{"date":"2021-12-31","value":-689200000,"profit":false},{"date":"2022-12-31","value":-818900000,"profit":false},{"date":"2023-12-31","value":-1078900000,"profit":false}] |
Pre-Tax Income | (14.56M) | (16.66M) | (43.08M) | (70.52M) | (63.28M) | [{"date":"2019-12-31","value":-1455700000,"profit":false},{"date":"2020-12-31","value":-1666400000,"profit":false},{"date":"2021-12-31","value":-4307500000,"profit":false},{"date":"2022-12-31","value":-7051800000,"profit":false},{"date":"2023-12-31","value":-6328300000,"profit":false}] |
Income Taxes | 194.00K | 42.00K | (140.00K) | 123.00K | 40.00K | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":21.65,"profit":true},{"date":"2021-12-31","value":-72.16,"profit":false},{"date":"2022-12-31","value":63.4,"profit":true},{"date":"2023-12-31","value":20.62,"profit":true}] |
Income After Taxes | (14.75M) | (16.71M) | (42.94M) | (70.64M) | (63.32M) | [{"date":"2019-12-31","value":-1475100000,"profit":false},{"date":"2020-12-31","value":-1670600000,"profit":false},{"date":"2021-12-31","value":-4293500000,"profit":false},{"date":"2022-12-31","value":-7064100000,"profit":false},{"date":"2023-12-31","value":-6332300000,"profit":false}] |
Income From Continuous Operations | (14.75M) | (16.71M) | (42.94M) | (70.64M) | (71.40M) | [{"date":"2019-12-31","value":-1475100000,"profit":false},{"date":"2020-12-31","value":-1670600000,"profit":false},{"date":"2021-12-31","value":-4293500000,"profit":false},{"date":"2022-12-31","value":-7064100000,"profit":false},{"date":"2023-12-31","value":-7139600000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (14.75M) | (16.71M) | (42.94M) | (70.64M) | (63.32M) | [{"date":"2019-12-31","value":-1475100000,"profit":false},{"date":"2020-12-31","value":-1670600000,"profit":false},{"date":"2021-12-31","value":-4293500000,"profit":false},{"date":"2022-12-31","value":-7064100000,"profit":false},{"date":"2023-12-31","value":-6332300000,"profit":false}] |
EPS (Diluted) | - | (0.20) | (4.52) | (1.88) | (1.43) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-20.5,"profit":false},{"date":"2021-12-31","value":-452,"profit":false},{"date":"2022-12-31","value":-188,"profit":false},{"date":"2023-12-31","value":-143,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
AKYA | |
---|---|
Cash Ratio | 1.28 |
Current Ratio | 2.75 |
Quick Ratio | 1.85 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
AKYA | |
---|---|
ROA (LTM) | -18.09% |
ROE (LTM) | -128.20% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
AKYA | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.90 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.10 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
AKYA | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 1.21 |
P/B | 8.25 |
Price/FCF | NM |
EV/R | 1.86 |
EV/Ebitda | NM |
Akoya Biosciences Inc (AKYA) share price today is $2.27
Yes, Indians can buy shares of Akoya Biosciences Inc (AKYA) on Vested. To buy Akoya Biosciences Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AKYA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Akoya Biosciences Inc (AKYA) via the Vested app. You can start investing in Akoya Biosciences Inc (AKYA) with a minimum investment of $1.
You can invest in shares of Akoya Biosciences Inc (AKYA) via Vested in three simple steps:
The 52-week high price of Akoya Biosciences Inc (AKYA) is $6.31. The 52-week low price of Akoya Biosciences Inc (AKYA) is $1.88.
The price-to-earnings (P/E) ratio of Akoya Biosciences Inc (AKYA) is
The price-to-book (P/B) ratio of Akoya Biosciences Inc (AKYA) is 8.25
The dividend yield of Akoya Biosciences Inc (AKYA) is 0.00%
The market capitalization of Akoya Biosciences Inc (AKYA) is $126.39M
The stock symbol (or ticker) of Akoya Biosciences Inc is AKYA